• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
TD1
Click for more information
0.00% 0.1¢

TALI DIGITAL LIMITED - Charts / Financials

Market Cap $3.295M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Tali Digital Ltd is a digital health company. The Company is focused on delivering... Tali Digital Ltd is a digital health company. The Company is focused on delivering diagnostic and therapeutic solutions to enhance attention and overall cognitive function. The Company has built a patented platform technology with the programs targeting cognitive attention skills during early childhood via an evidence-based screening tool (DETECT) incorporated into training modules (TRAIN, ReadyAttentionGo! and AttentionTime!). ReadyAttentionGo is an Australian medical device that is a digital therapeutic cognitive training program specifically designed to improve attention skills in children aged three-ten years. The product consists of an app where a child plays a series of digital games to improve attention skills, and a Web portal where a healthcare provider can gain vital insights into selective, sustained, and executive attention domains. It also delivers a series of product developments relevant to attention deficit hyperactivity disorder and autism spectrum disorder.More

refresh Created with Sketch. REFRESH
Last update - 10.00am 02/10/2024 (20 minute delay) ?
Day
Open 0.0¢   Day High 0.0¢   Day Low 0.0¢
Daily Volume 0
Bids   Sellers
Number Price Volume   Number Price Volume
10 0.1¢ 24715810   12 0.2¢ 26527964

Directors & Senior Management

Mr. Mark Anthony Simari Chairman of the Board
Ms. Mary Elizabeth Brinson Interim Chief Executive Officer, Chief Medical Officer
Mr. Tim Luscombe Company Secretary
Dr. David L. Brookes Non-Executive Director
Mr. Stephen J. Munday Additional Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
0.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $3.295M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
10 24715810 0.1¢
 

Sellers (Offers)

Price($) Vol. No.
0.2¢ 26527964 12
View Market Depth
Last trade - 07.00am 02/10/2024 (20 minute delay) ?

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Argent hits rockchips up to 24g/t gold at Trunkey Creek, NSW Argent Minerals has unveiled rockchips containing gold grading up to 24g/t on-site its NSW-based Trunkey Creek project acreage.
Canada orders national security review over CGN's 11.26% opposition to Paladin-Fission deal Paladin has disclosed its attempted takeover of Fission Uranium Corp was blocked by a Chinese shareholder late last month.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.